粵桂股份(000833.SZ):董事長、總經理等3高管因工作變動原因辭職
格隆匯12月13日丨粵桂股份(000833.SZ)公佈,2019年12月12日,公司收到黃祥清、方健寧、張棟富的辭職報告。
因工作變動,黃祥清辭去粵桂股份董事、董事長(法定代表人)、董事會戰略發展與投資決策委員會主任委員、提名委員會委員職務。辭去上述職務後,黃祥清將不在公司擔任任何職務。
因工作變動,方健寧辭去粵桂股份董事、總經理、董事會戰略發展與投資決策委員會委員、審計委員會委員、薪酬與考核委員會委員職務。辭去上述職務後,方健寧將不在公司擔任任何職務。
因工作變動,張棟富辭去粵桂股份董事、董事會戰略發展與投資決策委員會委員、審計委員會委員職務。辭去上述職務後,張棟富將不在公司擔任任何職務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.